(Q35196192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Safety and pharmacology of oseltamivir in clinical use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Penelope Ward

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1

Regina Dutkowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Bharat Thakrar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Enrico Froehlich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Pia Suter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

787-801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

Oral oseltamivir treatment of influenza in children.

6 November 2019

cites work

1 reference

12 December 2020

Adverse reactions to amantadine prophylaxis of influenza in a retirement home

1 reference

12 December 2020

Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults

1 reference

12 December 2020

Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial

1 reference

12 December 2020

Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirin

1 reference

12 December 2020

Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020

Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients

1 reference

12 December 2020

Oseltamivir distributes to influenza virus replication sites in the middle ear and sinuses.

1 reference

12 December 2020

Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids

1 reference

12 December 2020

Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

1 reference

12 December 2020

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

1 reference

12 December 2020

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

12 December 2020

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population

1 reference

12 December 2020

10.2165/00002018-200326110-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12908848%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 November 2019

1011612039

0 references

1 reference